Nanostring technologies, INC.:1165300 [16-054599]
Ended Awarded
- Contract number
- HHSN26100009
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,960
Award facts
- Contract value 100% obligated
- $24,960.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
NanoString Technologies, Inc. received a $24,960 firm fixed price contract award from the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health, on August 16, 2016. This award was issued as a call against a blanket purchase agreement (BPA), with an ultimate completion date of August 21, 2016 and no set-aside designation. The work is to be performed in Bethesda, Maryland. NanoString is a publicly traded provider of advanced genomic analysis platforms and life science tools, specializing in multiplexed digital detection technologies such as the nCounter Analysis Systems and GeoMx Digital Spatial Profiler, which are used for nucleic acid, protein, and cellular analysis in biomedical research applications.
Under this BPA call, NanoString is supplying specialized laboratory equipment, reagents, assays, and consumables to support the NCI's genomic and molecular analysis research initiatives. The company has an established history of providing similar products and services across multiple federal agencies, including the National Institutes of Health, Department of Veterans Affairs, Department of Defense, and the U.S. Department of Agriculture. NanoString's federal contract portfolio reflects its role as a critical supplier of advanced genomic analysis capabilities, with previous awards ranging from $10,000 to $496,250 for various systems, reagents, and analytical services supporting translational research and molecular diagnostics programs.
Quick answers
Who was awarded contract HHSN26100009?
HHSN26100009 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on August 16, 2016.
How much is contract HHSN26100009 worth?
The government has obligated $24,960 on HHSN26100009.
Is contract HHSN26100009 an order under another contract?
Yes. HHSN26100009 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract HHSN26100009 competed?
The extent of competition for HHSN26100009 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award